Bionow | News

Monument Therapeutics Launches First Clinical Study of MT1988, a Novel Treatment...

Nov 27th 2024

Monument Therapeutics, a precision neuroscience company, today announced the first participant has been successfully dosed in its Phase I clinical study of MT1988, a novel treatment targetin...

Lung cancer study offers further evidence on importance of screening

Jun 5th 2024

Researchers from the University of Liverpool and Queen Mary University of London have published the first study in the UK to demonstrate the benefits of lung cancer screening across socioeco...

Study Transformative Oncology, online and part-time at The University of Manches...

Mar 31st 2024

Delivered in collaboration with the Manchester Cancer Research Centre and designed with working professionals in mind, this pioneering, patient-focussed course will give you the tools to lea...

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the tre...

Jan 5th 2024

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease

First patient dosed in Phase 1 Trial

Oct 23rd 2023

Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2

PharmaKure announces study success for novel blood test to identify biomarkers i...

Oct 17th 2023

Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease

Discovering "a new normal" for contract research organisations

May 3rd 2023

To further understand the supply chain complexities for CROs, Biocair recently conducted a qualitative research study with CRO supply chain professionals.

PharmaKure has launched a study to identify blood-based biomarkers in patients w...

Oct 4th 2022

PharmaKure has launched a study to examine the relationship between blood biomarkers and historical PET scans or CSF in patients with Mild Cognitive Impairment due to Alzheimer’s Disease.

World's first COVID-19 vaccine alternating dose study launches in Liverpool

Feb 4th 2021

Study will examine using different vaccines for the two doses, as well as different intervals between doses

How kindness aligns with a growth mindset to foster positive mental health benef...

May 26th 2020

For Mental Health Awareness Week 2020 we look into how having a growth mindset can positively impact your mental wellbeing.

New dementia study to explore impact of COVID-19 social services cuts

Apr 23rd 2020

University of Liverpool working with collaborators at UCLAN, Lancaster University, University of Bradford, and UCL are investigating the wider national picture of the effects of social care ...

Boyds acquires Blue Duck Consultancy Ltd

Sep 5th 2019

Leading pharmaceutical and biotech product development consultancy Boyds has enhanced its clinical and medical affairs services offering following the acquisition of Blue Duck Consulting.

News